Key facts
- Titan Intake’s last known valuation is $6.0M (May 2025).
- It has raised $1.9M; the latest was Seed Round ($1.3M) in May 2025.
- Notable investors include Plug and Play Tech Center, SaaS Ventures, Tau Ventures, ACT House, Amplify.LA — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Titan Intake
- ·The full record, as it builds
Funding rounds
No funding rounds for Titan Intake are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Titan Intake
Developer of AI-based patient intake software designed to automate the patient referral process. The company's software helps specialty medical clinics to increase revenue by netting new patients, improve labor productivity through automation, and increase the patient care experience through faster onboarding and treatment, enabling healthcare professionals to reduce the processing of large referral packets.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Tulsa, OK, United States
- Founded
- 2022
- Employees
- 9
- Website
- titanintake.com/
- Ownership
- Privately Held (backing)
Titan Intake doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Titan Intake shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Titan Intake in its N-PORT filings yet. We sweep new filings monthly.